References
- Rapini RP, Warner NB. Relapsing polychondritis. Clin Dermatol. 2008;24:482–5.
- Gergely P Jr, Poor G. Relapsing polychondritis. Best Pract Res Clin Rheumatol. 2004;18:723–38.
- Lang B, Rothenfusser A, Lanchbury JS, Rauh G, Breedveld FC, Urlacher A, et al. Susceptibility to relapsing polychondritis is associated with HLA-DR4. Arthritis Rheum. 1993;36:660–4.
- Hellmich B, Hering S, Duchna HW, Schultze-Weminghaus G, Freitag L, Schatz H, et al. Airway manifestations of relapsing polychondritis: treatment with cyclophosphamide and placement of bronchial stents. Z Rheumatol. 2003;62:73–9.
- Hoang-Xaun T, Foster CS, Rice BA. Scleritis in relapsing poly-chondritis. Response to therapy. Ophthalmology. 1990;97:892–8.
- Lipnick RN, Fink CW. Acute airway obstruction in relapsing polychondritis: treatment with pulse methylprednisolone. J Rheumatol. 1991;18:98–9.
- Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, et al. The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept. Ann Rheum Dis. 2011;70: 284–8.
- Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, et al. Relapsing polychondritis: an autoimmune disease with many faces. Autoimmun Rev. 2010;9:540–6.
- Seymour MW, Home DM, Williams RO, Allard SA. Prolonged response to anti-tumour necrosis factor treatment with ada-limumab (Humira) in relapsing polychondritis complicated by aortitis. Rheumatology (Oxford). 2007;46:1738–9.
- Yamaoka K, Saito K, Hanami K, Nakayamada S, Nawata M, Iwata S, et al. A case of life-threatening refractory polychondritis successfully treated with combined intensive immunosuppressive therapy with methotrexate. Mod Rheumatol. 2007;17:144–7.
- Mpofu S, Estrach C, Curtis J, Moots RJ. Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology (Oxford). 2003;42:1117–8.
- Lahmer T, Knopf A, Treiber M, Heemann U, Thuermel K. Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab. Clin Rheumatol. 2010;29:1331–4.
- Hansson AS, Johannesson M, Svensson L, Nandakumar KS, Heinegard D, Holmdahl R. Relapsing polychondritis, induced in mice with matrilin 1, is an antibody- and complement-dependent disease. Am J Pathol. 2004;164:959–66.
- Buckner JH, Van Landeghen M, Kwok WW, Tsarknaridis L. Identification of type II collagen peptide 261-273-specific T cell clones in a patient with relapsing polychondritis. Arthritis Rheum. 2002;46:238–44.
- Stabler T, Piette JC, Chevalier X, Marini-Portugal A, Kraus VB. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum. 2004;50: 3663–7.